Structural insights into the HBV receptor and bile acid transporter NTCP

[1]  S. Alakurtti,et al.  Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids , 2020, Scientific Reports.

[2]  Conrad C. Huang,et al.  UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.

[3]  E. Blanchard,et al.  Hepatitis B Virus Entry into Cells , 2020, Cells.

[4]  F. Zoulim,et al.  Can we cure hepatitis B virus with novel direct‐acting antivirals? , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[5]  Tae-Young Kim,et al.  Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors. , 2019, Journal of pharmaceutical and biomedical analysis.

[6]  S. V. D. van de Graaf,et al.  Mechanistic insights into the inhibition of NTCP by myrcludex B , 2019, JHEP reports.

[7]  K. Schoonjans,et al.  NTCP deficiency in mice protects against obesity and hepatosteatosis , 2019, JCI insight.

[8]  S. Raunser,et al.  SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM , 2019, Communications Biology.

[9]  A. Ryo,et al.  Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization , 2019, Proceedings of the National Academy of Sciences.

[10]  S. V. D. van de Graaf,et al.  Developments in bile salt based therapies: A critical overview , 2019, Biochemical pharmacology.

[11]  M. Muramatsu,et al.  A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity , 2018, Journal of Virology.

[12]  Erik Lindahl,et al.  New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.

[13]  Jasenko Zivanov,et al.  A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis , 2018, bioRxiv.

[14]  Wei Tian,et al.  CASTp 3.0: computed atlas of surface topography of proteins , 2018, Nucleic Acids Res..

[15]  S. Iwata,et al.  Generation of Conformation-Specific Antibody Fragments for Crystallization of the Multidrug Resistance Transporter MdfA. , 2018, Methods in molecular biology.

[16]  T. Pillot,et al.  Structural and functional analyses of pyroglutamate-amyloid-β-specific antibodies as a basis for Alzheimer immunotherapy , 2017, The Journal of Biological Chemistry.

[17]  D. Agard,et al.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.

[18]  N. Grigorieff,et al.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs , 2015, bioRxiv.

[19]  Hiromu Suzuki,et al.  Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis , 2014, Cancer science.

[20]  Z. Abbas,et al.  Treatment of Chronic Hepatitis D Patients with Pegylated Interferon: A Real-World Experience , 2014, Antiviral therapy.

[21]  V. Lohmann,et al.  Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. , 2014, Journal of hepatology.

[22]  Hussein H. Aly,et al.  Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. , 2014, Biochemical and biophysical research communications.

[23]  Wenhui Li,et al.  Viral Entry of Hepatitis B and D Viruses and Bile Salts Transportation Share Common Molecular Determinants on Sodium Taurocholate Cotransporting Polypeptide , 2014, Journal of Virology.

[24]  M. Quick,et al.  Structural basis of the alternating-access mechanism in a bile acid transporter , 2013, Nature.

[25]  M. Muramatsu,et al.  Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID) , 2013, The Journal of Biological Chemistry.

[26]  David L. Dotson,et al.  A two-domain elevator mechanism for sodium/proton antiport , 2013, Nature.

[27]  A. Lohse,et al.  The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. , 2013, Journal of hepatology.

[28]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[29]  Y. Kanai,et al.  Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With α-Alkyl Moieties , 2012, Journal of Pharmacological Sciences.

[30]  Rianne A. M. Bouwmeester,et al.  Homo- and hetero-dimeric architecture of the human liver Na⁺-dependent taurocholate co-transporting protein. , 2012, The Biochemical journal.

[31]  S. Iwata,et al.  Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT , 2011, Nature.

[32]  F. Negro,et al.  Hepatitis D virus: an update , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[33]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[34]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[35]  J. Dubuisson,et al.  CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection , 2007, Journal of Virology.

[36]  Yuichi Sugiyama,et al.  Inhibition of Bile Acid Transport across Na+/Taurocholate Cotransporting Polypeptide (SLC10A1) and Bile Salt Export Pump (ABCB 11)-Coexpressing LLC-PK1 Cells by Cholestasis-Inducing Drugs , 2006, Drug Metabolism and Disposition.

[37]  S. Urban,et al.  Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. , 2005, Gastroenterology.

[38]  Hartmut Michel,et al.  Structure of a Na+/H+ antiporter and insights into mechanism of action and regulation by pH , 2005, Nature.

[39]  S. Urban,et al.  Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein , 2004, Journal of Virology.

[40]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[41]  R. Roberts,et al.  Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate Recognition* , 2004, Journal of Biological Chemistry.

[42]  H. Nakauchi,et al.  CD226 (DNAM-1) Is Involved in Lymphocyte Function–associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and Proliferation , 2003, The Journal of experimental medicine.

[43]  R. Henderson,et al.  Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. , 2003, Journal of molecular biology.

[44]  W. Gerlich,et al.  Pre-S1 Antigen-Dependent Infection of Tupaia Hepatocyte Cultures with Human Hepatitis B Virus , 2003, Journal of Virology.

[45]  D. Shouval.  Hepatitis B vaccines. , 2003, Journal of hepatology.

[46]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[47]  H. Nakauchi,et al.  Lentiviral vector-mediated transduction of murine CD34(-) hematopoietic stem cells. , 2002, Experimental hematology.

[48]  H. Blum,et al.  Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo , 1996, Hepatology.